Icon Advisers Inc Abb Vie Inc. Transaction History

Icon Advisers Inc

$426 Million
Q4 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $3.32 Million - $3.81 Million	-24,761 Reduced 57.02%	18,665 $2.51 Million
Q2 2022 Aug 11, 2022	SELL	$137.62 - $174.96 $467,908 - $594,864	-3,400 Reduced 7.26%	43,426 $6.65 Million
Q1 2022 May 26, 2022	SELL	$131.98 - $163.75 $1.55 Million - $1.93 Million	-11,760 Reduced 20.07%	46,826 $7.59 Million
Q4 2020 Feb 02, 2021	SELL	$80.49 - $108.67 $265,617 - $358,611	-3,300 Reduced 5.33%	58,586 $6.28 Million
Q3 2020 Nov 05, 2020	BUY	$85.91 - $100.83 $1.55 Million - $1.81 Million	18,000 Added 41.02%	61,886 $5.42 Million
Q2 2020 Aug 03, 2020	BUY	$73.37 - $98.18 $775,154 - $1.04 Million	10,565 Added 31.71%	43,886 $4.31 Million
Q1 2020 May 01, 2020	BUY	$64.5 - $97.79 $457,950 - $694,309	7,100 Added 27.08%	33,321 $2.54 Million
Q3 2019 Nov 01, 2019	SELL	$62.98 - $75.72 $4.02 Million - $4.83 Million	-63,768 Reduced 70.86%	26,221 $1.99 Million
Q2 2019 Aug 02, 2019	SELL	$65.7 - $83.98 $985,500 - $1.26 Million	-15,000 Reduced 14.29%	89,989 $6.54 Million
Q1 2019 May 01, 2019	BUY	$77.14 - $90.79 $455,126 - $535,661	5,900 Added 5.95%	104,989 $8.46 Million
Q3 2018 Nov 05, 2018	SELL	$88.91 - $98.84 $1.59 Million - $1.76 Million	-17,846 Reduced 15.26%	99,089 $9.37 Million
Q2 2018 Aug 03, 2018	SELL	$89.78 - $106.23 $370,162 - $437,986	-4,123 Reduced 3.41%	116,935 $10.8 Million
Q1 2018 Apr 30, 2018	BUY	$92.01 - $123.21 $5.88 Million - $7.88 Million	63,958 Added 112.01%	121,058 $11.5 Million
Q3 2017 Nov 08, 2017	BUY	$69.85 - $89.22 $3.99 Million - $5.09 Million	57,100	57,100 $5.07 Million

Others Institutions Holding ABBV

# of Institutions

4,095

Shares Held

1.28B

Call Options Held

16.7M

Put Options Held

15M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $357B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Icon Advisers Inc, based on Form 13F filings with the SEC.

News

Stay updated on Icon Advisers Inc with notifications on news.

Account